Fastnib-Forte is a specialized prescription medication designed for the management of moderate to severe rheumatoid arthritis and psoriatic arthritis. The active ingredient, Tofacitinib, is a Janus Kinase (JAK) inhibitor that works by blocking specific signals in the body that cause inflammation. Unlike traditional pain relievers, Fastnib-Forte targets the immune system’s overactive response at a cellular level, helping to reduce joint swelling, stiffness, and pain. The “Extended Release” formulation ensures a steady delivery of the medication into the bloodstream, providing consistent relief and making it easier for patients to manage their daily symptoms with a simplified dosing schedule. By controlling the progression of joint damage, Fastnib-Forte plays a crucial role in maintaining physical function and improving the overall quality of life for patients suffering from autoimmune orthopedic conditions. It represents the cutting edge of chronic arthritis care within the Human Orthocare portfolio.